Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
09/2010
09/30/2010US20100249093 Substituted Heteroarylpiperidine Derivatives As Melanocortin-4 Receptor Modulators
09/30/2010US20100249092 Heteroaryl compounds and uses thereof
09/30/2010US20100249088 Azolecarboxamide compound or salt thereof
09/30/2010US20100249085 Heteroaryl substituted pyrazole derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
09/30/2010US20100249084 Substituted pyrimidines as adenosine receptor antagonists
09/30/2010US20100249078 Tetracyclic inhibitors of fatty acid amide hydrolase
09/30/2010US20100249067 Modulators of Mitotic Kinases
09/30/2010US20100249063 Amorphous body composed of heterocyclic compound, solid dispersion and pharmaceutical preparation each comprising the same, and process for production of the same
09/30/2010US20100249049 Arylalkylamine compound and process for preparing the same
09/30/2010US20100247534 Fused heterocyclic compounds as inhibitors of potassium channel function
09/30/2010US20100247514 Gamma secretase modulators
09/30/2010US20100247468 Compounds that modulate PPAR gamma-type receptors and cosmetic/pharmaceutical compositions comprising said compounds
09/30/2010US20100244670 Heterocyclic Compound and Light-Emitting Element, Light-Emitting Device, Lighting Device, and Electronic Device Using the Same
09/30/2010DE102009014484A1 Substituierte Piperidine Substituted piperidines
09/30/2010CA2756255A1 Substituted bicyclic hcv inhibitors
09/30/2010CA2756178A1 Compounds as cannabinoid receptor ligands
09/30/2010CA2756172A1 Inhibitors of hepatitis c virus replication
09/30/2010CA2756067A1 Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
09/30/2010CA2756005A1 Substituted piperidines as par-1 antagonists
09/30/2010CA2755910A1 Inhibitors of nf-kb
09/30/2010CA2755680A1 P2x3, receptor antagonists for treatment of pain
09/30/2010CA2754184A1 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010CA2754176A1 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010CA2754103A1 Process for the preparation of propionic acid derivatives
09/29/2010EP2233485A1 Fluorophore-containing compounds and their use in the detection of phosphorylated (poly)peptides
09/29/2010EP2233484A2 Oxazolidinone derivatives having a 7-membered heterocyclic ring
09/29/2010EP2233483A1 Indole or Benzimidazole derivatives as IkB-kinase modulators and intermediates in their preparation.
09/29/2010EP2233480A1 Chemical compounds
09/29/2010EP2233473A1 3,5-di(aryl or heteroaryl)isoxazoles and 1,2,4-oxadiazoles as S1P1 receptor agonists, immunosuppresssive and anti-inflammatory agents
09/29/2010EP2233472A1 Heterocyclic compounds and uses thereof in the treatment of sexual disorders
09/29/2010EP2233470A1 Histamine H3 receptor antagonists
09/29/2010EP2231679A1 Synthesis of biguanidines and triazines, and biguanidino-aluminium complexes as intermediates
09/29/2010EP2231651A1 Isoxazolo-pyridazine derivatives
09/29/2010EP2231650A1 Isoxazole derivatives as modulators of 11-beta-hydroxysteroid dehydrogenase type 1
09/29/2010EP2231649A1 Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
09/29/2010EP2231648A1 New salts and crystal forms
09/29/2010EP2231641A2 Quinoxaline and quinoline derivatives as kinase inhibitors
09/29/2010EP2231640A1 Beta-amino acid derivatives for treatment of diabetes
09/29/2010EP2231629A1 Modulators for amyloid beta
09/29/2010EP2231625A1 Thiazole and oxazole kinase inhibitors
09/29/2010EP2231621A1 Process for preparing n-substituted hydroxypyrimidinone carboxamides
09/29/2010EP2231620A1 Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation
09/29/2010EP2231615A1 Cannabinoid receptor modulators
09/29/2010EP2231602A1 Gamma secretase modulators
09/29/2010EP2231558A1 3,4-substituted pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
09/29/2010EP2230913A1 Insecticidal compounds
09/29/2010EP1904490B1 Ethanolamine salt of n- (3-methoxy-5-methylpyrazin-2yl) -2- (4- [1 , 3 , 4-0xadiaz0le-2-yl]phenyl) pyridine-3- sulphonamide
09/29/2010EP1863801B1 Benzimidazole derivative and use thereof
09/29/2010EP1534695B1 Tyrosine kinase inhibitors
09/29/2010EP1421074B1 Novel compounds
09/29/2010EP1086950B1 Heterocyclic indole derivatives and mono- or diazaindole derivatives
09/29/2010CN1821217B Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative
09/29/2010CN101848882A 电致发光器件 Electroluminescent devices
09/29/2010CN101845043A Ortho heterocycle formanilide compound and synthesis method and application thereof
09/29/2010CN101845042A Oxadiazole derivative, light-emitting element, display device, lighting device, and electronic device
09/29/2010CN101031565B Substituted 2h-1,3-benzoxazin-4(3h)-ones
09/29/2010CN101006082B Histamine H3 receptor agents, preparation and therapeutic uses
09/29/2010CN101006076B Modulators of ATP-binding cassette transporters
09/28/2010US7803954 Mandelic acid derivatives and their use as thrombin inhibitors
09/28/2010US7803944 Viral polymerase inhibitors
09/28/2010US7803939 N2,N4-bis(4-ethoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors
09/28/2010US7803841 EP2 receptor agonists
09/28/2010US7803832 N-(1-arylpyrazol-4L)sulfonamides and their use as parasiticides
09/28/2010US7803820 Schizophrenia; bioavailability, solubility, brain penetrancy; in vivo half life; synthesis; such as 3-[3-({4-methyl-5-[4-(pentafluoro-6-sulfanyl)phenyl]-4H-1,2,4-triazol-3-yl}thio)propyl]-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane
09/28/2010US7803819 dipeptidyl peptidase IV (DPP-IV) inhibitors, such as 2S)-1-{[(1S)-2-(5-cyano-2-methyl-indol-1-yl)-1-methyl-ethylamino]-acetyl}-pyrrolidine-2-carbonitrile, useful for the treatment and/or prophylaxis non-insulin dependent diabetes and impaired glucose tolerance; antidiabetic agents
09/28/2010US7803797 Substituted arylcyclopentenes as therapeutic agents
09/28/2010CA2553160C 2-heteroaryl-substituted benzimidazole derivative
09/28/2010CA2383524C Thiazolyl alkynyl compounds and methods of use thereof
09/28/2010CA2383257C Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans
09/23/2010WO2010108067A1 Alpha-(n-benzenesulfonamido)cycloalkyl derivatives
09/23/2010WO2010108052A2 Amide derivatives as neuropeptide y5 receptor ligands
09/23/2010WO2010107997A1 Thiophenyl sulfonamides for the treatment of alzheimer's disease
09/23/2010WO2010107768A1 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
09/23/2010WO2010107765A1 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
09/23/2010WO2010106988A1 Amide derivative
09/23/2010WO2010106081A1 Piperidine derivatives as nk3 receptor antagonists
09/23/2010WO2010105770A1 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
09/23/2010WO2010083872A3 Materials for organic electroluminescence devices
09/23/2010WO2009127948A8 4- [3- (aryloxy) benzylidene] -3-methyl piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors
09/23/2010US20100240891 Drug containing benzophenone derivative or its salt
09/23/2010US20100240889 Urea Derivatives Methods For Their Manufacture And Uses Thereof
09/23/2010US20100240721 desoxyepothilone A and B; Fludelone; anticarcinogenic agents; drug resistance; water solubility for formulability; industrial scale; cytotoxic or growth inhibitory effects on CAG myeloma cells lines; ability to polymerize tubulin; minimum toxicity; stabilizing microtubules
09/23/2010US20100240718 Novel heteroaryl-substituted acetone derivative, suitable for inhibiting phospholipase a2
09/23/2010US20100240717 Novel thiophene derivatives as s1p1/edg1 receptor agonists
09/23/2010US20100240715 Apoptosis promoters
09/23/2010US20100240708 Alpha-(N-Benzenesulfonamido)Cycloalkyl Derivatives
09/23/2010US20100240677 Compounds as PDE IV and TNF Inhibitors
09/23/2010US20100240659 Nitrogen-containing heterocyclic derivative having 11ss-hydroxysteroid dehydrogenase type i inhibitory activity
09/23/2010US20100240658 Oxadiazole Derivatives
09/23/2010US20100240657 Chemical compounds
09/23/2010US20100240656 Compounds as hsp90 inhibitors
09/23/2010US20100240655 Bromo-phenyl substituted thiazolyl dihydropyrimidines
09/23/2010US20100240654 Hydrazide derivatives
09/23/2010US20100240653 Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto
09/23/2010US20100240652 Pyridine Derivatives as Sodium Channel Modulators
09/23/2010US20100240651 Water-soluble thalidomide derivatives
09/23/2010US20100240650 Substituted pyrrolines as kinase inhibitors
09/23/2010US20100240649 Quinazoline and quinoline derivatives as irreversible protein tyrosine kinase inhibitors
09/23/2010US20100240648 Hexahydro-pyrrolo-isoquinoline compounds
09/23/2010US20100240644 Morpholine derivative
1 ... 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 ... 647